Health utility scores for people with type 2 diabetes in U.S. managed care health plans: Results from translating research into action for diabetes (TRIAD)

Diabetes Care

Volumn 35, Issue 11, 2012, Pages 2250-2256

  Zhang, Ping ^a   Brown, Morton B ^b   Bilik, Dori ^c   Ackermann, Ronald T ^d   Li, Rui ^a   Herman, William H ^c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; AMPUTATION; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; COST UTILITY ANALYSIS; DIABETIC NEUROPATHY; DIALYSIS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEMIPLEGIA; HUMAN; ISCHEMIC HEART DISEASE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PROSPECTIVE STUDY; QUALITY OF LIFE; RELIABILITY; RISK FACTOR; SCORING SYSTEM; SYNDROME DELINEATION; TRANSIENT ISCHEMIC ATTACK; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; YOUNG ADULT;

EID: 84868100490     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-2478     Document Type: Article

References (24)

1. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in Health and Medicine. New York, Oxford University Press, 1996
2. Coffey JT, Brandle M, Zhou H, et al. Valuing health-related quality of life in diabetes. Diabetes Care 2002;25:2238-2243
3. Bagust A, Beale S. Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data. Health Econ 2005;14:217-230
4. Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 2002;22: 340-349
5. Solli O, Stavem K, Kristiansen IS. Health-related quality of life in diabetes: the associations of complications with EQ-5D scores. Health Qual Life Outcomes 2010;8:18
6. Sach TH, Barton GR, Jenkinson C, Doherty M, Avery AJ, Muir KR. Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter? Med Care 2009;47:889-894
7. Johnson JA, Coons SJ, Ergo A, Szava- Kovats G. Valuation of EuroQOL (EQ-5D) health states in an adult US sample. Pharmacoeconomics 1998;13:421-433
8. Johnson JA, Luo N, Shaw JW, Kind P, Coons SJ. Valuations of EQ-5D health states: are the United States and United Kingdom different? Med Care 2005;43: 221-228
9. BharmalM, Thomas J 3rd. Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population. Value Health 2006;9: 262-271
10. Sullivan PW, LawrenceWF,GhushchyanV. A national catalog of preference-based scores for chronic conditions in the United States. Med Care 2005;43:736-749
11. Grandy S, Fox KM. EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Health Qual Life Outcomes 2008;6:18
12. TRIAD Study Group. The Translating Research Into Action for Diabetes (TRIAD) study: a multicenter study of diabetes in managed care. Diabetes Care 2002;25: 386-389
13. Kim C, Williamson DF, Mangione CM, et al.; Translating Research Into Action for Diabetes (TRIAD) Study. Managed care organization and the quality of diabetes care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 2004;27:1529-1534
14. Glasziou P, Alexander J, Beller E, Clarke P; ADVANCE Collaborative Group. Which health-related quality of life score? A comparison of alternative utility measures in patients with type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes 2007;5:21
15. Carlin JB, Galati JC, Royston P. A new framework for managing and analyzing multiply imputed data in Stata. Stata J 2008;8:49-67
16. Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care 1998;21(Suppl. 3):C11-C14
17. Hoerger TJ, Zhang P, Segel JE, Gregg EW, Narayan KM, Hicks KA. Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy. Diabetes Res Clin Pract 2009; 86:225-232
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383
19. Funnell MM. Quality of life and insulin therapy in type 2 diabetes mellitus. Insulin 2008;3:31-36
20. Hlatky MA, Chung SC, Escobedo J, et al.; BARI 2D Study Group. The effect of obesity on quality of life in patients with diabetes and coronary artery disease. Am Heart J 2010;159:292-300
21. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999; 15:205-218
22. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE,Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 2002; 25:458-463
23. US Inflation Calculator [article online], 2012. Available from http://www. usinflationcalculator.com/. Accessed 14 May 2012
24. Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L.Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 1997;20:562-567